SYMBIO PHARMA Trademark

Trademark Overview

On Tuesday, May 2, 2023, a trademark application was filed for SYMBIO PHARMA with the United States Patent and Trademark Office. The USPTO has given the SYMBIO PHARMA trademark a serial number of 97917514. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, February 6, 2024. This trademark is owned by SymBio Pharmaceuticals Limited. The SYMBIO PHARMA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations for the treatment of viral, oncological, neurological diseases and disorders; pharmaceutical preparations, namely, suspensions, nasal sprays for medical purposes and eye drops; empty capsules for pharmaceuticals; lactose for medical purposes; vectors for gene therapy; vaccines for gene therapy; reagents for use in medical genetic testing; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of blood disorder; pharmaceutical preparations for the prevention, treatment and diagnostic of cancer; antitumor drugs; pharmaceutical preparations for transdermal infusion; patches for medical treatment; anti-nauseants; capsules for medicines; capsules for pharmaceutical purposes; testing and diagnostic preparations for medical purposes; antivirals; cotton swabs for medical use; testing kits for virus infection; diagnostic kits for virus infection

Medical diagnostic apparatus for testing for viruses
symbio pharma

General Information

Serial Number97917514
Word MarkSYMBIO PHARMA
Filing DateTuesday, May 2, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, February 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of viral, oncological, neurological diseases and disorders; pharmaceutical preparations, namely, suspensions, nasal sprays for medical purposes and eye drops; empty capsules for pharmaceuticals; lactose for medical purposes; vectors for gene therapy; vaccines for gene therapy; reagents for use in medical genetic testing; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; pharmaceutical preparations for the treatment of blood disorder; pharmaceutical preparations for the prevention, treatment and diagnostic of cancer; antitumor drugs; pharmaceutical preparations for transdermal infusion; patches for medical treatment; anti-nauseants; capsules for medicines; capsules for pharmaceutical purposes; testing and diagnostic preparations for medical purposes; antivirals; cotton swabs for medical use; testing kits for virus infection; diagnostic kits for virus infection
Goods and ServicesMedical diagnostic apparatus for testing for viruses

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 31, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, May 31, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSymBio Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMinato-ku, Tokyo 105-0001
JP

Trademark Events

Event DateEvent Description
Friday, April 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 6, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 6, 2024NON-FINAL ACTION WRITTEN
Saturday, January 27, 2024ASSIGNED TO EXAMINER
Wednesday, May 31, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 5, 2023NEW APPLICATION ENTERED

Related Keywords

pharma symbio medical pharmaceutical preparations testing purposes diagnostic treatment capsules virus infection